The ethical perils of gene therapy

A six-year-old girl has died after receiving the first brain-based gene editing in the world. The procedure took place in China. The Financial Times and Medscape have both published articles on the ethical perils of gene therapy. The Herald Insight and Progress Educational Trust have both reported on the death. The child's death has sparked international debate about the ethics of gene therapy.

The scandal has also exposed the limits of China's scientific rise, according to Yahoo. The death of the child has raised questions about the safety and ethics of gene therapy. The procedure was experimental and had not been tested on humans before. The death has also raised questions about the regulation of gene therapy in China and other countries. The ethical perils of gene therapy are not limited to the death of this child.

The procedure raises questions about the potential for misuse and the need for international regulations. The death of the child has also highlighted the need for more research into the safety and efficacy of gene therapy. The scandal in China has also raised questions about the country's scientific rise and the need for greater transparency and accountability in its research practices.